Evaluation of the association between the JAK2 46/1 haplotype and myeloproliferative neoplasm in a Korean population.
作者信息
Park S-G, Ha J S
机构信息
Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea.
出版信息
Int J Lab Hematol. 2015 Aug;37(4):e91-5. doi: 10.1111/ijlh.12328. Epub 2015 Jan 28.
PMID:25630751
Abstract
摘要
相似文献
1
Evaluation of the association between the JAK2 46/1 haplotype and myeloproliferative neoplasm in a Korean population.韩国人群中JAK2 46/1单倍型与骨髓增殖性肿瘤之间关联的评估。
Int J Lab Hematol. 2015 Aug;37(4):e91-5. doi: 10.1111/ijlh.12328. Epub 2015 Jan 28.
2
Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.真性红细胞增多症、原发性血小板增多症以及原发性骨髓纤维化伴或不伴JAK2 V617F突变时的巨核细胞形态及临床参数
Arch Pathol Lab Med. 2014 Sep;138(9):1203-9. doi: 10.5858/arpa.2013-0018-OA.
3
Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients.巴西患者中TNF基因多态性与JAK2（V617F）骨髓增殖性肿瘤的关联。
Blood Cells Mol Dis. 2016 Mar;57:54-7. doi: 10.1016/j.bcmd.2015.12.005. Epub 2015 Dec 10.
4
Relationship between the 46/1 haplotype of the JAK2 gene and the JAK2 mutational status and allele burden, the initial findings, and the survival of patients with myelofibrosis.原发性骨髓纤维化患者 JAK2 基因 46/1 单体型与 JAK2 突变状态及等位基因负担的关系：初步研究结果与患者生存情况。
Ann Hematol. 2014 May;93(5):797-802. doi: 10.1007/s00277-013-1989-5. Epub 2013 Dec 15.
5
The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.JAK2 V617F时代真性红细胞增多症、原发性血小板增多症和原发性骨髓纤维化的诊断与管理
Clin Adv Hematol Oncol. 2009 May;7(5):334-42.
6
Prognostic factors and models in polycythemia vera, essential thrombocythemia, and primary myelofibrosis.真性红细胞增多症、特发性血小板增多症和原发性骨髓纤维化的预后因素和模型。
Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S25-7. doi: 10.1016/j.clml.2011.01.002. Epub 2011 Apr 29.
7
A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis.在原发性血小板增多症患者中，血小板中观察到的JAK2 V617F突变克隆比粒细胞中的更高，但真性红细胞增多症和原发性骨髓纤维化患者中并非如此。
Leukemia. 2007 Jun;21(6):1331-2. doi: 10.1038/sj.leu.2404649. Epub 2007 Mar 15.
8
Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).慢性骨髓增殖性疾病（MPD）、原发性血小板增多症（ET）、真性红细胞增多症（PV）和慢性特发性骨髓纤维化（CIMF）的现行诊断标准。
Pathol Biol (Paris). 2007 Mar;55(2):92-104. doi: 10.1016/j.patbio.2006.06.002. Epub 2006 Aug 21.
9
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.世界卫生组织真性红细胞增多症、原发性血小板增多症和原发性骨髓纤维化诊断标准的修订理由及拟议更改
Blood Cancer J. 2015 Aug 14;5(8):e337. doi: 10.1038/bcj.2015.64.
10
The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms.LNK基因多态性与骨髓增殖性肿瘤临床类型相关
PLoS One. 2016 Apr 25;11(4):e0154183. doi: 10.1371/journal.pone.0154183. eCollection 2016.
Zotero 插件